Market Overview

UPDATE: Stifel Nicolaus Cuts PT to $26 on Emeritus on Updated Estimates

Related ESC
Stocks Hitting 52-Week Highs
Updated Research Report on HCP - Analyst Blog

Stifel Nicolaus reiterated its Buy rating on Emeritus (NYSE: ESC) but reduced its estimates from $27.50 to $26.

Stifel Nicolaus commented, "We hosted meetings between Emeritus management and institutional investors. The company, like its senior housing peers, benefits from a favorable supply/demand dynamic that management expects to persist. … Management said that it chose to be a REIT tenant rather than a REIT joint venture partner for 133 former Sunwest facilities because it sees well above-average growth potential. Full consolidation rather than a minority interest allows it to capitalize on this. …The company acknowledges that its recent Nurse on Call home healthcare acquisition increases its exposure to Medicare, but sees operating opportunities and efficiencies that will offset the risks."

Emeritus closed at $21.69 on Wednesday.

Latest Ratings for ESC

DateFirmActionFromTo
Mar 2014Deutsche BankDowngradesBuyHold
Mar 2014JMP SecuritiesDowngradesMarket OutperformMarket Perform
Sep 2013Stifel NicolausMaintainsBuy

View More Analyst Ratings for ESC
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (ESC)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters